Effects of treatment latency on response to maintenance treatment in manic-depressive disorders

Bipolar Disorders

Volumn 9, Issue 4, 2007, Pages 386-393

  Baldessarini, Ross J ^a,b,g   Tondo, Leonardo ^a,b,c,d   Baethge, Christopher J ^e   Lepri, Beatrice ^c,d   Bratti, Irene M ^f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d Lucio Bini Mood Disorder Center   (Italy)

^e UNIVERSITY OF COLOGNE   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MCLEAN HOSPITAL   (United States)

Author keywords

Anticonvulsants; Antipsychotics; Bipolar disorder; Episode counts; Lithium; Manic depressive illness; Treatment latency; Treatment response

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; LITHIUM CARBONATE; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; MORBIDITY; MULTIVARIATE ANALYSIS; ONSET AGE; PRIORITY JOURNAL; RECURRENT DISEASE; THERAPY DELAY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM COMPOUNDS; LONG-TERM CARE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOTIC DISORDERS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34249875186     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2007.00385.x     Document Type: Article

References (35)

1. Tondo L, Hennen J, Baldessarini RJ. Meta-analysis of treatment responses of rapid cycling and non-rapid cycling bipolar disorder patients. Acta Psychiatr Scand 2003; 104: 4-14.
2. Franchini L, Zanardi R, Smeraldi E, Gasperini M. Early onset of lithium prophylaxis as a predictor of good longterm outcome. Eur Arch Psychiatry Clin Neurosci 1999; 249: 227-230.
3. Kessing LV, Andersen PK. Effect of episodes on recurrence in affective disorder: A case register study. J Affect Disord 1999; 53: 225-231.
4. Post RM, Weiss SR. Neurobiological models of recurrence in mood disorder. In: Charney DS, Nestler EJ, Bunney BS eds. Neurobiology of Mental Illness. New York: Oxford University Press, 1999: 365-384.
5. Yazici O, Kora K, Ucok A, Tumali D, Ruan N. Predictors of lithium prophylaxis in bipolar patients. J Affect Disord 1999; 55: 133-142.
6. MacQueen GM, Young LT, Robb et al. Effect of number of episodes on wellbeing and functioning in patients with bipolar disorder. Acta Psychiatr Scand 2000; 101: 374-381.
7. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Mania: differential effects of previous manic and depressive episodes on response to treatment. Acta Psychiatr Scand 2000; 101: 444-451.
8. Cutler NR, Post RM. Life course of illness in untreated manic-depressive patients. Compr Psychiatry 1982; 23: 101-115.
9. Amann B, Grunze H. Neurochemical underpinnings in bipolar disorder and epilepsy. Epilepsia 2005; 46: 26-30.
10. Marneros A, Deister A, Rohde A. Affective, schizoaffective and schizophrenic psychoses: Comparative longterm study. Monogr Gesamtgeb Psychiatr Psychiatry Ser 1991; 65: 1-454.
11. Kessing LV, Andersen PK. Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders. Curr Psychiatry Rep 2005; 7: 413-420.
12. Trede K, Salvatore P, Baethge C, Gerhard A, Maggini C, Baldessarini RJ. Manic-depressive illness: Evolution in Kraepelin's Textbook, 1883-1926. Harv Rev Psychiatry 2005; 13: 155-178.
13. Slater E. On the periodicity of manic-depressive insanity. Z Gesamte Neurol Psychiatrie 1938; 162: 794-801.
14. Oepen G, Salvatore P, Baldessarini RJ. On the periodicity of manic-depressive insanity by Eliot Slater (1938): Translation and commentary. J Affect Disord 2004; 78: 1-9.
15. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders: Naturalistic study, 1994-1999. Br J Psychiatry 2004; 185: 372-377.
16. Haghighat R. Lifelong development of risk of recurrence in depressive disorders. J Affect Disord 1996; 41: 141-147.
17. Turvey CL, Coryell WH, Solomon DA et al. Longterm prognosis of bipolar I disorder. Acta Psychiatr Scand 1999; 99: 110-119.
18. Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 2000; 48: 445-457.
19. Tondo L, Baethge C, Baldessarini RJ. Does earlier intervention improve response to mood-stabilizing treatment? Bipolar Disord 2005; 7(Suppl. 2): 107-108.
20. Baethge C, Baldessarini RJ, Bratti IM, Tondo L. Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry 2003; 48: 449-457.
21. Bratti IM, Baldessarini RJ, Baethge C, Tondo L. Pretreatment episode count and response to lithium treatment in manic-depressive illness. Harv Rev Psychiatry 2003; 11: 245-256.
22. Baldessarini RJ, Tondo L, Hennen J, Floris G. Latency and episodes before treatment; response to lithium maintenance in bipolar I and II disorders. Bipolar Disord 1999; 2: 91-97.
23. Baethge C, Gruschka P, Smolka MN et al. Effectiveness and outcome predictors of longterm lithium prophylaxis in unipolar major depressive disorder. J Psychiatry Neurosci 2003; 28: 355-361.
24. Baethge C, Smolka MN, Gruschka P et al. Does prophylaxis delay in bipolar disorder influence outcome? Results from a longterm study of 147 patients. Acta Psychiatr Scand 2003; 107: 260-267.
25. Baldessarini RJ, Tondo L, Hennen J. Treatment latency and previous episodes: Relationship to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord 2003; 5: 169-179.
26. Baethge C, Gruschka P, Berghöfer A et al. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: Outcome after longterm follow-up. J Affect Disord 2004; 79: 43-50.
27. Baldessarini RJ, Tondo L, Faedda GL et al. Latency, discontinuation, and re-use of lithium treatment. In: Bauer M, Grof P, Müller-Oerlinghausen B eds. Lithium in Neuropsychiatry: The Comprehensive Guide. London: Taylor & Francis, 2006: 465-481.
28. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: Follow-up over 34-38years. J Affect Disord 2002; 68: 167-181.
29. Tondo L, Isacsson G, Baldessarini RJ. Suicide in bipolar disorder: Risk and prevention. CNS Drugs 2003; 17: 491-511.
30. Angst J, Angst F, Gerber-Werder R, Gamma A. Suicide in 406 mood disorder patients with and without longterm medication: A 40 to 44-year follow-up. Arch Suicide Res 2005; 9: 279-300.
31. Maj M, Akiskal HS, Lopez-Ibor JJ, Sartorius N (eds). Evidence and Experience in Psychiatry, Vol. 5: Bipolar Disorder. New York: John Wiley & Sons, 2002: 97-280.
32. Grof P, Hux M, Grof E, Arato M. Prediction of response to stabilizing lithium treatment. Pharmacopsychiatria 1983; 16: 195-200.
33. Kulhara P, Basu D, Mattoo SK, Sharan P, Chopra R. Lithium prophylaxis of recurrent bipolar affective disorder: Longterm outcome and its psychosocial correlates. J Affect Disord 1999; 54: 87-96.
34. Maj M, Pirozzi R, Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J Affect Disord 1989; 17: 237-241.
35. Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C. Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry 1991; 148: 1237-1239.